CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 12,000 shares at $8.57 ($102,796)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Former 10% Owner acquired 6,411,355 shares (conversion)
- 4 Open-market buy 10% owner bought 250,000 shares at $24.00 ($6,000,000)
- 4 Open-market buy Director bought 250,000 shares at $24.00 ($6,000,000)
- 4 Conversion Director acquired 11,295 shares (conversion)
- 4 Open-market buy Director bought 41,666 shares at $24.00 ($999,984)
Page 5 of 7 · 127 filings